Search Results 11-20 of 16590 for immunothérapie Bylaska

  1. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas - Mayo Clinic

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  2. Immunotherapy Of Vestibular Function Impact - Mayo Clinic

    The purpose of this study is to determine if immunotherapy checkpoint inhibitors influence vestibular function. Participation eligibility. Participant ...

  3. Myeloid Cell Interactions Modulate Combination Immunotherapy Outcomes in the Liver Tumor Microenvironment - Mayo Clinic Research

    This proposal in the Career Enhancement Program of the Mayo Clinic Hepatobiliary SPORE studies research models of cancer and immune cells interacting during ...

  4. Tumor Immunology and Immunotherapy - Department of Cancer Biology - Mayo Clinic Research

    The Department of Cancer Biology at Mayo Clinic is developing strategies to stimulate the immune system to target cancer cells for tumor regression and ...

  5. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    TG4010 has been developed for use as an immunotherapy in cancer patients whose tumors express the MUC1 antigen. TG4010 is intended to induce a MUC1-specific ...

  6. Biological therapy for cancer - Care at Mayo Clinic

    Immunotherapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy. Accessed Feb. 10, 2025 ...

  7. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    A new study explores the combination of the intratumoral administration of the measles virus with systemic PD-L1 targeted immunotherapy using atezolizumab ...

  8. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

    An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove ...

  9. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  10. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which ...